TREK- 1 Ameliorates Secondary Brain Injury by Regulating Inflammatory Microenvironment via CX3 CL1-CX3 CR1 Pathway After Intracerebral Hemorrhage
- PMID: 40279035
- DOI: 10.1007/s12035-025-04950-1
TREK- 1 Ameliorates Secondary Brain Injury by Regulating Inflammatory Microenvironment via CX3 CL1-CX3 CR1 Pathway After Intracerebral Hemorrhage
Abstract
Neuroinflammation plays a pivotal role in the pathogenesis of secondary brain injury (SBI) after intracerebral hemorrhage (ICH). TREK-1 is a background potassium channel, and its role in regulating neuroinflammation after ICH remains unclear. In this study, ICH models were induced in wide-type (WT) and TREK knockout mice via intra-striatal administration of collagenase. Additionally, WT ICH mice were treated with the TREK-1 agonist ML67-33. Immunofluorescence, western blot, quantitative real-time PCR, enzyme-linked immunosorbent assay, and RNA-sequencing were performed to determine the role and the mechanism of TREK-1 in regulating neuroinflammation after ICH. The results indicate that TREK-1 deficiency exacerbated microglia/macrophages activation and pro-inflammatory polarization, as well as the influx of inflammatory cytokines and peripheral inflammatory cells compared to WT ICH mice. Conversely, activation of TREK-1 attenuated the inflammatory response and SBI post-ICH. These effects may be mediated through the CX3CL1-CX3CR1 pathway, as validated by specific inhibitors AZD8797. This study identified TREK-1 as a crucial modulator in alleviating SBI by regulating the inflammatory microenvironment via the CX3CL1-CX3CR1 pathway.
Keywords: CX3 CL1-CX3 CR1; Inflammatory microenvironment; Intracerebral hemorrhage; Secondary brain injury; TREK- 1.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval: All animal experimental protocols were authorized by the Institutional Animal Care and Use Committee of Tongji Medical College, Huazhong University of Science and Technology (Ethics approval number: TJH- 202001002). Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Gut microbiota-derived phenylacetylglutamine mitigates neuroinflammation induced by intracerebral hemorrhage in mice.J Stroke Cerebrovasc Dis. 2025 Aug;34(8):108357. doi: 10.1016/j.jstrokecerebrovasdis.2025.108357. Epub 2025 May 28. J Stroke Cerebrovasc Dis. 2025. PMID: 40446981
-
miR-210 Regulates Autophagy Through the AMPK/mTOR Signaling Pathway, Reduces Neuronal Cell Death and Inflammatory Responses, and Enhances Functional Recovery Following Cerebral Hemorrhage in Mice.Neurochem Res. 2025 Jun 5;50(3):180. doi: 10.1007/s11064-025-04434-7. Neurochem Res. 2025. PMID: 40471451 Free PMC article.
-
Microglial STING activation promotes neuroinflammation and pathological changes in experimental mice with intracerebral haemorrhage.Acta Pharmacol Sin. 2025 Sep;46(9):2376-2392. doi: 10.1038/s41401-025-01540-8. Epub 2025 Apr 8. Acta Pharmacol Sin. 2025. PMID: 40200123
-
CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease.Int J Mol Sci. 2023 May 4;24(9):8230. doi: 10.3390/ijms24098230. Int J Mol Sci. 2023. PMID: 37175935 Free PMC article. Review.
-
Targeting the NLRP3-ROS Axis: Disrupting the Oxidative-Inflammatory Vicious Cycle in Intracerebral Hemorrhage.J Inflamm Res. 2025 Jul 24;18:9849-9870. doi: 10.2147/JIR.S529884. eCollection 2025. J Inflamm Res. 2025. PMID: 40735267 Free PMC article. Review.
References
-
- Ma Q, Li R, Wang L, Yin P, Wang Y, Yan C, Ren Y, Qian Z et al (2021) Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 6(12):e897–e906. https://doi.org/10.1016/s2468-2667(21)00228-0 - DOI - PubMed - PMC
-
- GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol 20(10):795–820. https://doi.org/10.1016/s1474-4422(21)00252-0 - DOI
-
- Liddle LJ, Ralhan S, Ward DL, Colbourne F (2020) Translational intracerebral hemorrhage research: has current neuroprotection research ARRIVEd at a standard for experimental design and reporting? Transl Stroke Res 11(6):1203–1213. https://doi.org/10.1007/s12975-020-00824-x - DOI - PubMed - PMC
-
- Rennert RC, Signorelli JW, Abraham P, Pannell JS, Khalessi AA (2015) Minimally invasive treatment of intracerebral hemorrhage. Expert Rev Neurother 15(8):919–933. https://doi.org/10.1586/14737175.2015.1059755 - DOI - PubMed
-
- Li Z, Khan S, Liu Y, Wei R, Yong VW, Xue M (2022) Therapeutic strategies for intracerebral hemorrhage. Front Neurol 13:1032343. https://doi.org/10.3389/fneur.2022.1032343 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous